Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse

Despite highly intensive multimodality treatment regimens, the prognosis of patients with high-risk neuroblastoma (HRNB) and central nervous system (CNS) relapse remains poor. We retrospectively reviewed data from 13 patients with HRNB and CNS relapse who received multimodal therapy with consolidati...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaadt, Tim, Ebinger, Martin, Schreiber, Malin, Ladenstein, Ruth L., Simon, Thorsten, Lode, Holger N., Hero, Barbara, Schuhmann, Martin U., Schäfer, Jürgen, Paulsen, Frank, Timmermann, Beate, Eggert, Angelika, Lang, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573405/
https://www.ncbi.nlm.nih.gov/pubmed/37834840
http://dx.doi.org/10.3390/jcm12196196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573405/
https://www.ncbi.nlm.nih.gov/pubmed/37834840
http://dx.doi.org/10.3390/jcm12196196

Ejemplares similares